Add like
Add dislike
Add to saved papers

Circadian incidence of non-inflammatory retinal artery occlusions.

BACKGROUND AND PURPOSE: Myocardial infarction and stroke tend to occur in the morning. We were interested in discovering when the onset of visual loss occurred in patients with retinal artery occlusion (RAO). Assuming that the therapeutic time slot is about 2 to 6 hours, a cumulated incidence during the night might have therapeutic implications.

METHODS: We retrospectively evaluated the data of 266 patients (175 male and 91 female patients) with non-inflammatory RAO: 211 patients with central retinal artery occlusion (CRAO), 36 patients with branch retinal artery occlusion (BRAO), and 19 patients with hemi-central retinal artery occlusion (hemi-CRAO).

RESULTS: Nocturnal visual loss occurred in 25 patients (9.4%). Ocular deterioration during the day was recorded in 173 patients (65.1%). Visual loss at waking was recorded in 59 patients (22.2%). In most patients with short-term latency (
CONCLUSIONS: Visual loss due to ocular arterial occlusions can occur at any time. Visual deterioration has been recorded more often during the day than during the night.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app